Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21097 | 373 | 44.5 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASCULAR ENDOTHELIAL DYSFUNCTION | Author keyword | 4 | 27% | 3% | 13 |
2 | MOL CARDIOBIOL PROGRAM | Address | 3 | 27% | 2% | 9 |
3 | VASCULAR ENDOTHELIUM DYSFUNCTION | Author keyword | 3 | 50% | 1% | 4 |
4 | BOYER MOL MED PHARMACOL | Address | 2 | 67% | 1% | 2 |
5 | NITRIC OXIDE CHEMILUMINESCENCE | Author keyword | 2 | 67% | 1% | 2 |
6 | DIS GRP CARDIOVASC AGENTS | Address | 2 | 50% | 1% | 3 |
7 | VASC CELL SIGNALING THER EUT PROGRAM | Address | 2 | 50% | 1% | 3 |
8 | PROGRAM VASC CELL SIGNALING THER EUT | Address | 2 | 31% | 1% | 5 |
9 | DAVIS HEART LUNG 605 | Address | 1 | 100% | 1% | 2 |
10 | ENOS MUTANTS | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AKT DEPENDENT PHOSPHORYLATION | 11 | 29% | 8% | 31 |
2 | DUAL ACYLATION | 5 | 60% | 2% | 6 |
3 | STRESS STIMULATES PHOSPHORYLATION | 5 | 31% | 3% | 13 |
4 | SER1179 | 4 | 75% | 1% | 3 |
5 | THREONINE 495 | 3 | 100% | 1% | 3 |
6 | INDEPENDENT ENOS ACTIVATION | 3 | 38% | 2% | 6 |
7 | ENOS ACTIVATION | 3 | 20% | 3% | 12 |
8 | PLASMALEMMAL CAVEOLAE | 2 | 16% | 3% | 12 |
9 | ENOS PHOSPHORYLATION | 2 | 23% | 2% | 7 |
10 | PALMITOYLATION SITES | 1 | 21% | 2% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation | 2007 | 225 | 69 | 46% |
Life history of eNOS: Partners and pathways | 2007 | 190 | 132 | 36% |
eNOS activation and NO function: Structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity | 2011 | 52 | 112 | 26% |
Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase | 2003 | 499 | 133 | 31% |
Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium | 2013 | 13 | 178 | 31% |
Subcellular targeting and trafficking of nitric oxide synthases | 2006 | 69 | 117 | 31% |
Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase | 2013 | 4 | 89 | 38% |
Endothelial nitric oxide synthase: the Cinderella of inflammation? | 2003 | 104 | 42 | 40% |
Regulation of endothelial nitric oxide synthase: Location, location, location | 2002 | 335 | 95 | 18% |
Submaximal PPAR gamma activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders | 2012 | 12 | 93 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CARDIOBIOL PROGRAM | 3 | 27% | 2.4% | 9 |
2 | BOYER MOL MED PHARMACOL | 2 | 67% | 0.5% | 2 |
3 | DIS GRP CARDIOVASC AGENTS | 2 | 50% | 0.8% | 3 |
4 | VASC CELL SIGNALING THER EUT PROGRAM | 2 | 50% | 0.8% | 3 |
5 | PROGRAM VASC CELL SIGNALING THER EUT | 2 | 31% | 1.3% | 5 |
6 | DAVIS HEART LUNG 605 | 1 | 100% | 0.5% | 2 |
7 | PEDIAT SURG PHARMACOL TOXICOL | 1 | 100% | 0.5% | 2 |
8 | ABT ANAESTHESIOL OPERAT INTENSIVMED | 1 | 50% | 0.3% | 1 |
9 | BIOGERON | 1 | 50% | 0.3% | 1 |
10 | INTERUNIV GENOM GENE TECHNOL | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165792 | MOL INNOVAT DRUG DISCOVERY//N HYDROXYGUANIDINES//LERNER FDN |
2 | 0.0000131639 | CAVEOLIN 1//CAVEOLAE//CAVEOLIN |
3 | 0.0000108660 | SHEAR STRESS//CYCLIC STRAIN//HEMODYNAMIC FORCE |
4 | 0.0000102245 | ST EUGENIO CTO A ALESINI HOSP//CYCLIC GUANYLYL MONOPHOSPHATE//CIBER PATHOPHYSIOL OBES NUTR |
5 | 0.0000101217 | ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE//ENOS GENE//ENOS POLYMORPHISM |
6 | 0.0000099249 | NUTRITIVE FLOW//NON NUTRITIVE FLOW//INSULIN TRANSPORT |
7 | 0.0000086340 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
8 | 0.0000075886 | INTERVAL SPRINT TRAINING//DIABET CARDIOVASC HLTH//DIABET CARDIOVASC BIOL PROGRAM |
9 | 0.0000075417 | CL EXTRACELLULAR//RB 86 FLUX//RECEPTOR OPERATED CA2 CHANNEL |
10 | 0.0000072512 | VASCULAR AGING//REYNOLDS OKLAHOMA AGING//ENDOTHELIUM DEPENDENT DILATION |